NCT06184360
- Conditions
- Eye Diseases, Macular Degeneration, Neovascular (Wet) Age-related Macular Degeneration, +2 more
- Locations
-
- Novartis East Hanover, New Jersey, United States
Clinical trial condition
Neovascular (Wet) Age-related Macular Degeneration
Explore clinical trials studying Neovascular (Wet) Age-related Macular Degeneration. Study availability and eligibility vary by location and protocol.
15 public trials
3 recruiting studies
Neovascular (Wet) Age-related Macular Degeneration trial results
NCT04126317
- Conditions
- Eye Diseases, Macular Degeneration, Neovascular (Wet) Age-related Macular Degeneration, +2 more
- Locations
-
- Regeneron Study Site Phoenix, Arizona, United States
- Regeneron Study Site Sun City, Arizona, United States
- Regeneron Study Site Encino, California, United States
- Regeneron Study Site Fullerton, California, United States
Completed
Observation of Treatment Patterns With Lucentis® in Real-life Conditions in All Approved Indications
NCT04847895
- Conditions
- Cardiovascular Diseases, Choroid Diseases, Choroidal Neovascularization, +15 more
- Locations
-
- Novartis Investigative Site Ettlingen, Baden-Wurttemberg, Germany
- Novartis Investigative Site Ahaus, Germany
- Novartis Investigative Site Andernach, Germany
- Novartis Investigative Site Augsburg, Germany
Active, Not Recruiting
Switch From 2mg Aflibercept to 8mg Aflibercept in Patients With Neovascular Age-related Macular Degeneration
NCT07390253
- Conditions
- Eye Diseases, Macular Degeneration, Neovascular (Wet) Age-related Macular Degeneration, +2 more
- Locations
-
- Vienna Institute for Research in Ocular Surgery Vienna, Austria
Active, Not Recruiting
Recurrence and Predictive OCT Biomarkers in Quiescent Neovascular AMD
NCT06717139
- Conditions
- Disease Attributes, Eye Diseases, Macular Degeneration, +6 more
- Locations
-
- St Erik Eye Hospital Stockholm, Solna, Sweden